Influence of Tyrphostin AG490 on the expression of diabetes-associated markers in human adipocytes
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Influence of Tyrphostin AG490 on the expression of diabetes-associated markers in human adipocytes
Authors
Keywords
Adipocytes, Diabetes, Kinase inhibitor, Autoimmunity, AG490, Obesity
Journal
IMMUNOGENETICS
Volume 65, Issue 1, Pages 83-90
Publisher
Springer Nature
Online
2012-10-19
DOI
10.1007/s00251-012-0659-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Tyrphostin AG490 Agent Modestly but Significantly Prevents Onset of Type 1 in NOD Mouse; Implication of Immunologic and Metabolic Effects of a Jak-Stat Pathway Inhibitor
- (2012) Abdoreza Davoodi-Semiromi et al. JOURNAL OF CLINICAL IMMUNOLOGY
- The Tyrphostin Agent AG490 Prevents and Reverses Type 1 Diabetes in NOD Mice
- (2012) Abdoreza Davoodi-Semiromi et al. PLoS One
- Correspondence regarding “Long term treatment with ACE inhibitor enalapril decreases body weight gain and increases life span in rats”
- (2011) Abdoreza Davoodi-Semiromi et al. BIOCHEMICAL PHARMACOLOGY
- Small molecule tyrosine kinase inhibitors for the treatment of intestinal inflammation
- (2011) Maninder Sidhu et al. INFLAMMATORY BOWEL DISEASES
- Tyrosine Kinase Inhibitors Ameliorate Autoimmune Encephalomyelitis in a Mouse Model of Multiple Sclerosis
- (2011) Oliver Crespo et al. JOURNAL OF CLINICAL IMMUNOLOGY
- STAT5A Expression in Swiss 3T3 Cells Promotes Adipogenesis In Vivo in an Athymic Mice Model System
- (2011) William C. Stewart et al. Obesity
- Emerging roles of JAK–STAT signaling pathways in adipocytes
- (2011) Allison J. Richard et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Neuropoietin activates STAT3 independent of LIFR activation in adipocytes
- (2010) Ursula A. White et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- JAK2 inhibitors: What's the true therapeutic potential?
- (2010) Fabio P.S. Santos et al. BLOOD REVIEWS
- Tyrphostins as Potential Therapeutic Agents for Acute Kidney Injury
- (2010) S. Goncalves et al. CURRENT MEDICINAL CHEMISTRY
- JAK2/STAT3 pathway is involved in the early stage of adipogenesis through regulatingC/EBPβtranscription
- (2010) Kunming Zhang et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Potential utility of small tyrosine kinase inhibitors in the treatment of diabetes
- (2009) Dariush Mokhtari et al. CLINICAL SCIENCE
- Janus kinases in immune cell signaling
- (2009) Kamran Ghoreschi et al. IMMUNOLOGICAL REVIEWS
- Differential Transcriptional Expression of PPARα, PPARγ1, and PPARγ2 in the Peritoneal Macrophages and T-cell Subsets of Non-obese Diabetic Mice
- (2009) Nik-Soriani Yaacob et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Transcriptional factors that promote formation of white adipose tissue
- (2009) Ursula A. White et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Human SGBS Cells – a Unique Tool for Studies of Human Fat Cell Biology
- (2008) Pamela Fischer-Posovszky et al. Obesity Facts
- Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice
- (2008) C. Louvet et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started